Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIRAT study of proteomic biomarkers of aspirin and thienopyridine resistance in stable coronary artery disease
2007-006686-32Phase 3Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Clínico San Carlos
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prasugrel, clopidogrel and aspirin in coronary arteriosclerosis (2 cohorts), sponsored by Fundación para la Investigación Biomédica del Hospital Clínico San Carlos. Started Mar 2008; status: active.
02
Drugs
prasugrelclopidogrelaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2007-006686-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006686-32.